Cargando…
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332914/ https://www.ncbi.nlm.nih.gov/pubmed/32629139 http://dx.doi.org/10.1016/j.tmaid.2020.101819 |
| _version_ | 1783553631775096832 |
|---|---|
| author | Lebeaux, David Revest, Matthieu |
| author_facet | Lebeaux, David Revest, Matthieu |
| author_sort | Lebeaux, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7332914 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73329142020-07-06 No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” Lebeaux, David Revest, Matthieu Travel Med Infect Dis Article Elsevier Ltd. 2020 2020-07-03 /pmc/articles/PMC7332914/ /pubmed/32629139 http://dx.doi.org/10.1016/j.tmaid.2020.101819 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Lebeaux, David Revest, Matthieu No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title_full | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title_fullStr | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title_full_unstemmed | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title_short | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France” |
| title_sort | no evidence of clinical benefits of early treatment of covid-19 patients with hydroxychloroquine and azithromycin: comment on “early treatment of covid-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in marseille, france” |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332914/ https://www.ncbi.nlm.nih.gov/pubmed/32629139 http://dx.doi.org/10.1016/j.tmaid.2020.101819 |
| work_keys_str_mv | AT lebeauxdavid noevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycincommentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance AT revestmatthieu noevidenceofclinicalbenefitsofearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycincommentonearlytreatmentofcovid19patientswithhydroxychloroquineandazithromycinaretrospectiveanalysisof1061casesinmarseillefrance |